{
  "timestamp": "20250104_013603",
  "model": "gpt-4o-mini",
  "interaction_type": "answer_normal_rag",
  "question_id": "427393cb",
  "question_text": "Which of the following drug is contraindicated in a patient of myasthenia gravis: September 2008",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on retrieved medical knowledge."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.Please help answer this multiple choice question:\n\n    Question: Which of the following drug is contraindicated in a patient of myasthenia gravis: September 2008\n\n    Options:\n    opa. Succinylcholine\nopb. Tubocurare\nopc. Pyridostigmine\nopd. Halothane\n\n### Retrieved Similar Medical Knowledge:\n- Vasculitis CAUSES Thrombosed aneurysm\n- PROK2 INTERACTS_WITH EIF2S1\n- Pharmacologic Substance TREATS Myasthenia Gravis\n- ALDH3A1 gene|ALDH3A1 PART_OF Exosomes\n- Wall of intestine LOCATION_OF Bacteria, Anaerobic\n- agonists TREATS Myasthenia Gravis\n- Pyridostigmine TREATS Myasthenia Gravis, Generalized\n- Neuromuscular Blocking Agents TREATS Myasthenia Gravis\n- hyperfunction ASSOCIATED_WITH HLA-Bw51\n- Anesthetics TREATS Myasthenia Gravis\n- Pharmaceutical Preparations COMPLICATES Myasthenia Gravis\n\n    ### Instructions:\n            - Use standard medical knowledge as the primary guide.\n            - Consider enhanced information only if it aligns with consensus.\n            - If conflicting or unclear, present the most likely correct answer based on known facts.\n            - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n    ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n                \n    ### Output Format\n    Provide your response in valid JSON format:\n    {   \n        \"final_analysis\": \"Your analysis of how the retrieved relationships support the answer\",\n        \"answer\": \"Option key from the available options (only key, like opa)\",\n        \"confidence\": Score between 0-100 based on evidence strength and relevance\n    }\n    "
    }
  ],
  "response": "{\n    \"final_analysis\": \"In patients with myasthenia gravis, the use of neuromuscular blocking agents can exacerbate muscle weakness. Succinylcholine is a depolarizing neuromuscular blocker that can lead to significant complications in these patients due to its mechanism of action, which can worsen the neuromuscular transmission issues inherent in myasthenia gravis. Tubocurare, another neuromuscular blocker, also poses similar risks. Pyridostigmine is actually a treatment for myasthenia gravis, and halothane is an anesthetic that can be used with caution. Therefore, the most contraindicated drug in this context is succinylcholine.\",\n    \"answer\": \"opa\",\n    \"confidence\": 90\n}",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4o-mini",
    "temperature": 0.0
  }
}